• In early August 2026, Palantir Technologies reported second-quarter 2026 results showing sales of US$1,935.46 million and net income of US$1,061.89 million, alongside raised full-year 2026 revenue guidance to between US$8.15–US$8.16 billion and an expectation of GAAP operating income and net income in every remaining quarter.
• On the same day, Mercury Systems announced a new agreement with Palantir to use its software to automate material planning and build a digital twin of Mercury’s operations, tying Palantir’s AI platforms even more closely to critical U.S. defense supply chains and production capacity.
• Next, we’ll examine how Palantir’s sharply higher profitability and upgraded full-year guidance could reshape its longer-term investment narrative.

We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Palantir Technologies Investment Narrative Recap

To own Palantir, you need to believe its enterprise AI platforms can stay mission critical for governments and large corporations while justifying a premium valuation. The latest quarter’s strong profitability and higher 2026 guidance reinforce that story in the near term, but the biggest risk remains concentration in U.S. defense and commercial demand at a time when the stock already prices in very high expectations.

The new agreement with Mercury Systems looks especially relevant here: it embeds Palantir’s software deeper into U.S. defense supply chains and production workflows. That directly supports the core AI adoption catalyst, but it also increases the company’s exposure to shifting U.S. defense budgets and political scrutiny around sensitive military programs.

Yet behind the strong headline numbers, the concentration of growth in U.S. defense related work is something investors should be aware of as...

Palantir Technologies' narrative projects $10.8 billion revenue and $3.6 billion earnings by 2028. This requires 40.7% yearly revenue growth and about a $2.5 billion earnings increase from $1.1 billion today.

Uncover how Palantir Technologies' forecasts yield a $185.70 fair value, a 7% upside to its current price.

Exploring Other Perspectives

Before this report, the most optimistic analysts were modeling about US$11.9 billion of revenue and US$4.9 billion of earnings by 2028, which is far more aggressive than the baseline view. If you agree that U.S. centric growth and defense heavy contracts could eventually slow or face pushback, this upbeat narrative may look very different after such a strong quarter and the latest Mercury partnership.

Explore 58 other fair value estimates on Palantir Technologies - why the stock might be worth less than half the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Palantir Technologies research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Palantir Technologies research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Palantir Technologies' overall financial health at a glance.

Curious About Other Options?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• The future of work is here. Discover the 37 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• Capitalize on the AI infrastructure supercycle with our selection of the 55 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.